3528 results for «2025-12-19至2026-01-05+智光电气+异动分析»
3528 results
TAVI for aortic regurgitation in high surgical risk: outcomes in 700 patients from ALIGN-AR
12 Feb 2026 – From PCR London Valves 2025
Christopher Allen and Raj Makkar sit down to review the ALIGN-AR trial and its implications for treating native aortic regurgitation.
ALIGN-AR was a pivotal, single-arm, multicenter investigational study designed to evaluate a dedicated transcatheter solution in patients with moderate-to-severe native AR who were considered high risk for...
How to successfully approach calcified bifurcation lesions?
20 May 2025 – From EuroPCR 2025
Calcified bifurcation lesions remain one of the toughest challenges in interventional cardiology, combining two high-risk features into one complex scenario.
In this discussion, Dejan Milasinovic, Miroslaw Ferenc, and Mohamed Abdel Wahab explain why this subset deserves dedicated attention. They highlight the critical role of intra-coronary imaging to...
How to successfully approach CTO interventions: a step-by-step approach
22 Oct 2025 – From EuroPCR 2025
Elliot Smith, Thomas Hovasse and Roberto Garbo discuss a comprehensive, step-by-step approach to CTO interventions, providing structured guidance on navigating CTOs in a safe and effective way.
The discussion begins with angiographic assessment, emphasising the importance of identifying key anatomical features upfront. Based on this evaluation, operators determine...
One-year results from the ADALA trial
16 Nov 2025 – From PCR London Valves 2025
Left atrial appendage (LAA) closure is a new focus at this year’s PCR London Valves Course, and, in this interview, Xavier Freixa and Christopher Allen discuss the ADALA trial and its impact on post-occlusion management.
The study compared three months of low-dose DOAC with three months of...
TARGET study interim results: safety and performance of Cardiovalve replacement system for tricuspid regurgitation
16 Nov 2025 – From PCR London Valves 2025
Georg Nickenig and Christopher Allen discuss transcatheter replacement for the tricuspid valve and a dedicated transfemoral device in this interview, focusing on the TARGET study.
TARGET set out to answer two questions: can tricuspid regurgitation (TR) be reduced to mild or zero, and what are the safety...
PARTNER 3 — 7-year follow-up: what it means for low-risk patients
16 Nov 2025 – From PCR London Valves 2025
Philippe Généreux and Philippe Pibarot discuss the long-term findings from PARTNER 3 and their practical implications for patient care.
They review the 7-year comparison of transfemoral TAVR versus surgical aortic-valve replacement in symptomatic patients with severe aortic stenosis who are at low surgical risk, and why the...
Early treatment of severe aortic stenosis: do we need to wait?
20 May 2025 – From EuroPCR 2025
Rahul Sharma and Darren Walters share their perspectives on shifting treatment strategies for aortic stenosis (AS), with a focus on early intervention.
Their conversation draws on the EARLY TAVR trial, which compared transcatheter aortic valve replacement (TAVR) to clinical surveillance in patients with severe, asymptomatic AS at low surgical...
Five-year outcomes following early experience with transapical TMVR
16 Nov 2025 – From PCR London Valves 2025
In this discussion, Christopher Allen and Michael Reardon review the five-year results of an early transapical TMVR system implanted in very high-risk, inoperable patients.
The device showed sustained elimination of mitral regurgitation, with over 80% of patients maintaining trace or no MR at five years and no...
Jump start the year with PCR Webinars!
08 Jan 2026
Step into 2026 with fresh perspectives! Explore the editorial by Dejan Milasinovic, PCR Webinars Medical Director, and discover the ideas shaping the year ahead.
The Programme is out for the PCR Fellows Course in Paris!
What is AICT-AsiaPCR?
What is PCR Gulf Valves?
Introducing the team behind PCR Tricuspid Focus Group
27 Apr 2021
Discover an overview of the new initiative’s mission and five ongoing working groups
PCR’s Got Talent: abstract competition
05 May 2023
EuroPCR’s abstract competition is a unique platform for practitioners to showcase their work to the international community.
A Multidisciplinary Core Team
12 Jun 2025
The three Directors have different specialties: Roberto Lorusso is a cardiac surgeon, Sascha Ott a cardiac intensivist and Flavio Ribichini a interventional cardiologist. 40 other healthcare practitioners will be assigned to one of 5 working groups:
- Patient and MCS device phenotyping
- Implantation and complication management
- Shock network and patient...
Hands-on Training Workshops
PCR Tricuspid Focus Group - referral meeting in Pisa
09 May 2024
Join your peers for this meeting on 22-23 September 2025 in Pisa, Italy!
PCR Tricuspid Focus Group - referral meeting in Bonn
13 Jun 2024
Join your peers for this meeting on 24 January 2025 in Bonn, Germany!
PCR Tricuspid Focus Group - referral meeting in Milan
10 Jul 2023
Join your peers for this meeting on 13-14 January 2025 in Milan, Italy!
PCR Tricuspid Focus Group - referral meeting in London
21 Mar 2023
Join your peers for this meeting on 10 January 2025 in London, United Kingdom!
